ML24100A025: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 23: | Line 23: | ||
==Purpose:== | ==Purpose:== | ||
Provide an opportunity to hear views from the Advisory | Provide an opportunity to hear views from the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on medical-related topics of regulatory interest. | ||
Scheduled: | |||
Scheduled: | April 9, 2024 10:00 am Duration: | ||
Approximately 2 hours Location: | |||
Duration: | Commissioners Hearing Room, 1st floor OWFN Panel 60 mins* | ||
Location: | |||
Panel | |||
Hossein Jadvar, M.D., Ph.D., ACMUI Chair Topic: | Hossein Jadvar, M.D., Ph.D., ACMUI Chair Topic: | ||
Overview of ACMUI activities Richard Harvey, DrPH, ACMUI Radiation Safety Officer Representative Topic: | |||
ACMUIs Review and Analysis of Reported Medical Events from Fiscal Years 2021-2023 Megan Shober, ACMUI Agreement State Representative Topic: | |||
Richard Harvey, DrPH, ACMUI Radiation Safety Officer Representative Topic: | ACMUI Comments on Revisions to Regulatory Guide 8.39, Release of Patients Administered Radioactive Material Josh Mailman, ACMUI Patients' Rights Advocate Topic: | ||
Patients Rights Advocates Perspectives on: | |||
o Regulatory Guide 8.39, Release of Patients Administered Radioactive Material o Reporting of Nuclear Medicine Injection Extravasations Commission Q & A 40 mins. | |||
Megan Shober, ACMUI Agreement State Representative Topic: | Discussion - Wrap-Up 5 mins. | ||
*For presentation only and does not include time for Commission Q & A}} | |||
Josh Mailman, ACMUI Patients' Rights Advocate Topic: | |||
o | |||
Commission Q & A | |||
Discussion - Wrap-Up | |||
*For presentation only and does not include time for Commission | |||
Latest revision as of 18:44, 24 November 2024
| ML24100A025 | |
| Person / Time | |
|---|---|
| Issue date: | 04/09/2024 |
| From: | NRC/OCM |
| To: | |
| Shared Package | |
| ML24060A004 | List: |
| References | |
| M240409B | |
| Download: ML24100A025 (1) | |
Text
AGENDA
Title:
MEETING WITH THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES (Public Meeting)
Purpose:
Provide an opportunity to hear views from the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on medical-related topics of regulatory interest.
Scheduled:
April 9, 2024 10:00 am Duration:
Approximately 2 hours2.314815e-5 days <br />5.555556e-4 hours <br />3.306878e-6 weeks <br />7.61e-7 months <br /> Location:
Commissioners Hearing Room, 1st floor OWFN Panel 60 mins*
Hossein Jadvar, M.D., Ph.D., ACMUI Chair Topic:
Overview of ACMUI activities Richard Harvey, DrPH, ACMUI Radiation Safety Officer Representative Topic:
ACMUIs Review and Analysis of Reported Medical Events from Fiscal Years 2021-2023 Megan Shober, ACMUI Agreement State Representative Topic:
ACMUI Comments on Revisions to Regulatory Guide 8.39, Release of Patients Administered Radioactive Material Josh Mailman, ACMUI Patients' Rights Advocate Topic:
Patients Rights Advocates Perspectives on:
o Regulatory Guide 8.39, Release of Patients Administered Radioactive Material o Reporting of Nuclear Medicine Injection Extravasations Commission Q & A 40 mins.
Discussion - Wrap-Up 5 mins.
- For presentation only and does not include time for Commission Q & A